Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10557-020-07044-3.pdf
Reference9 articles.
1. Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci. 2020;50(SI-1):620–32 Published 2020 Apr 21.
2. Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in covid-19 [published online ahead of print, 2020 Apr 30]. Heart. 2020; heartjnl-2020-317056.
3. Cizgici AY, Zencirkiran Agus H, Yildiz M. COVID-19 myopericarditis: it should be kept in mind in today's conditions. Am J Emerg Med. 2020;S0735-6757(20):30310–7.
4. Adler Y, Charron P, Imazio, et al. ESC guidelines for the diagnosis and management of pericardial diseases: the force for the diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;42:2921–64.
5. Buckley LF, Viscusi MM, Van Tassell BW, Abbate A. Interleukin-1 blockade for the treatment of pericarditis. Eur Heart J Cardiovasc Pharmacother. 2018;4(1):46–53.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapy of pericarditis with colchicine, interleukin-1 antagonists, immunosuppressants;Clinical Medicine (Russian Journal);2023-03-26
2. Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra);Rheumatology Science and Practice;2023-03-03
3. Using Natural Language Processing for Context Identification in COVID-19 Literature;Advances in Bioinformatics and Computational Biology;2023
4. Acute Pericarditis as the Primary Presentation of COVID-19 Infection followed by Guillain-Barre Syndrome in a Healthy Young Man: A Case Report;The Open Respiratory Medicine Journal;2022-12-12
5. Efficacy of Anakinra in Pericarditis: A Systematic Review;Cureus;2022-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3